A Phase I Trial of Proleukin and Rapamune in Recent-onset Type 1 Diabetes Mellitus (ITN018AI)
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Aldesleukin (Primary) ; Sirolimus (Primary)
 - Indications Type 1 diabetes mellitus
 - Focus Adverse reactions
 
Most Recent Events
- 23 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
 - 02 Jun 2010 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
 - 14 Jan 2010 New source identified and integrated (Oregon Health and Science University record no. IRB00005193).